Strategic funding Potential sales opportunity around expanding InheRET’s risk assessment tools into broader hereditary disease management, leveraging their $3.2M funding and NCI grant history to propose partnerships or enterprise licenses for healthcare providers and research institutions.

Healthcare partnerships Target health systems, oncology practices, and genetics clinics that would benefit from an online program enabling patient risk identification without visits, aligning with their 2019 online program launch and spinout status from University of Michigan.

Data & identity Position HubSpot Analytics and Cloud infrastructure as a strength for secure patient data handling; propose integrations with EHR/HL7 interfaces and identity authentication to streamline patient risk profiling for clinics and insurers.

Scale opportunities With a small team and revenue under one million, there is a clear need for scalable SaaS deployment, managed services, and channel partnerships to accelerate customer acquisition in mid-market and small healthcare providers.

Competitive edge Highlight differentiators such as personalized risk reduction strategies and rapid online risk assessment to attract collaborations with genealogy-health ecosystems and life sciences players seeking hereditary cancer risk tools.